Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSATM, as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study
Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSATM, as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study
复制标题
DOI：
10.1111/j.1464-410x.2011.10568.x
复制
发表时间：
2012-06-01
影响因子：
4.5
通讯作者：
Partin, Alan W.
中科院分区：
文献类型：
--
作者：
Lepor, Herbert;Cheli, Carol D.;Partin, Alan W.
研究类型 诊断（验证队列） 证据级别 1b 有关该主题的已知信息是什么？以及该研究增加了什么？最低点超敏感 PSA 水平对于预测 RD 后的 BCR 有一定价值。 AccuPSA 测定 PSA 定量下限
Study Type Diagnostic (validating cohort) Level of Evidence 1b What's known on the subject? and What does the study add? Nadir Ultrasensitive PSA levels has some value for predicting BCR following RD. AccuPSA assays lower limit of PSA quantification of